Order Article Reprints

Tomita N, Saito S, Terada-Hirashima J, Mikami A, Uemura Y, Kutsuna S, Nomoto H, Fujisawa K, Nagashima M, Terada M, et al. A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT). Life. 2022; 12(6):856. https://doi.org/10.3390/life12060856

Tomita, Noriko, Sho Saito, Junko Terada-Hirashima, Ayako Mikami, Yukari Uemura, Satoshi Kutsuna, Hidetoshi Nomoto, Kyoko Fujisawa, Maki Nagashima, Mari Terada, and et al. 2022. "A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)" Life 12, no. 6: 856. https://doi.org/10.3390/life12060856

Tomita, N., Saito, S., Terada-Hirashima, J., Mikami, A., Uemura, Y., Kutsuna, S., Nomoto, H., Fujisawa, K., Nagashima, M., Terada, M., Ashida, S., Morioka, S., Satake, M., Hangaishi, A., Togano, T., Shiratori, K., Takamatsu, Y., Maeda, K., Ohmagari, N., ... Mitsuya, H. (2022). A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT). Life, 12(6), 856. https://doi.org/10.3390/life12060856